Respiratory Viral Testing and Influenza Antiviral Prescriptions During Hospitalization for Acute Respiratory Illnesses.

Rolfes, Melissa A; Yousey-Hindes, Kimberly M; Meek, James I; Fry, Alicia M; Chaves, Sandra S.

Afiliação

Rolfes MA; Epidemic Intelligence Service; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Yousey-Hindes KM; Connecticut Emerging Infections Program , Yale School of Public Health , New Haven, Connecticut.
Meek JI; Connecticut Emerging Infections Program , Yale School of Public Health , New Haven, Connecticut.
Fry AM; Influenza Division , Centers for Disease Control and Prevention , Atlanta, Georgia.
Chaves SS; Influenza Division , Centers for Disease Control and Prevention , Atlanta, Georgia.

Open Forum Infect Dis ; 3(1): ofv216, 2016 Jan.

Article em En | MEDLINE | ID: mdl-26885545

ABSTRACT

We examined respiratory viral testing and influenza antiviral prescriptions at a US tertiary care hospital. During the 2010-11 to 2012-13 influenza seasons, antiviral prescriptions among acute respiratory illness (ARI) hospitalizations were associated with viral testing (rate ratio = 15.0), and empiric prescriptions were rare (<1% of ARI hospitalizations).

Palavras-chave

acute respiratory illness hospitalizations; influenza; influenza antivirals; respiratory virus testing

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article